New discoveries in obesity and related metabolic diseases: from bench to bed.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 541, doi. 10.1093/jmcb/mjab063
- By:
- Publication type:
- Article
Works matching IS 16742788 AND DT 2021 AND VI 13 AND IP 8
Results: 6
1
2
Benzo[a]pyrene stimulates miR-650 expression to promote the pathogenesis of fatty liver disease and hepatocellular carcinoma via SOCS3/JAK/STAT3 cascades.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 556, doi. 10.1093/jmcb/mjab052
- By:
- Publication type:
- Article
3
Multi-omics profiling: the way toward precision medicine in metabolic diseases.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 576, doi. 10.1093/jmcb/mjab051
- By:
- Publication type:
- Article
4
Lipidomics reveals association of circulating lipids with body mass index and outcomes in IgA nephropathy patients.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 565, doi. 10.1093/jmcb/mjab040
- By:
- Publication type:
- Article
5
Metabolic surgery in China: present and future.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 594, doi. 10.1093/jmcb/mjab039
- By:
- Publication type:
- Article
6
Knockdown of insulin-like growth factor 2 gene disrupts mitochondrial functions in the liver.
- Published in:
- Journal of Molecular Cell Biology, 2021, v. 13, n. 8, p. 543, doi. 10.1093/jmcb/mjab030
- By:
- Publication type:
- Article